APA (7th ed.) Citation

D, M., G, C., T, K., B, E., AM, V., C, E., . . . B, T. B. (2026). Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: Differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis. European journal of gastroenterology & hepatology, 38(5), 615. https://doi.org/10.1097/MEG.0000000000003142

Chicago Style (17th ed.) Citation

D, Malino, et al. "Clinical Course and Prognostic Risk Factors of SARS-CoV-2 Vaccine-related Hepatitis: Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-associated Liver Injury from Autoimmune Hepatitis." European Journal of Gastroenterology & Hepatology 38, no. 5 (2026): 615. https://doi.org/10.1097/MEG.0000000000003142.

MLA (9th ed.) Citation

D, Malino, et al. "Clinical Course and Prognostic Risk Factors of SARS-CoV-2 Vaccine-related Hepatitis: Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-associated Liver Injury from Autoimmune Hepatitis." European Journal of Gastroenterology & Hepatology, vol. 38, no. 5, 2026, p. 615, https://doi.org/10.1097/MEG.0000000000003142.